Related Experiment Video
Updated: Sep 3, 2025

Author Spotlight: Advancements in Stem Cell Regenerative Therapy Through Photobiomodulation
Published on: April 5, 2024
Therapeutic Potential of Photobiomodulation for Chronic Kidney Disease
Ji Bian1, Ann Liebert2,3, Brian Bicknell3
1Kolling Institute, Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Royal North Shore Hospital, St Leonards, NSW 2065, Australia.
Abstract:
Chronic kidney disease (CKD) is a growing global public health problem. The implementation of evidence-based clinical practices only defers the development of kidney failure. Death, transplantation, or dialysis are the consequences of kidney failure, resulting in a significant burden on the health system. Hence, innovative therapeutic strategies are urgently needed due to the limitations of current interventions. Photobiomodulation (PBM), a form of non-thermal light therapy, effectively mitigates mitochondrial dysfunction, reactive oxidative stress, inflammation, and gut microbiota dysbiosis, all of which are inherent in CKD. Preliminary studies suggest the benefits of PBM in multiple diseases, including CKD. Hence, this review will provide a concise summary of the underlying action mechanisms of PBM and its potential therapeutic effects on CKD. Based on the findings, PBM may represent a novel, non-invasive and non-pharmacological therapy for CKD, although more studies are necessary before PBM can be widely recommended.
Insights
Photobiomodulation (PBM) therapy shows promise for chronic kidney disease (CKD) by addressing key disease mechanisms. This non-invasive light treatment may offer a novel therapeutic avenue for CKD patients.
Area of Science:
- Nephrology
- Biomedical Engineering
- Light Therapy
Background:
- Chronic kidney disease (CKD) is a significant global health issue.
- Current interventions for CKD only delay kidney failure, highlighting the need for innovative treatments.
- CKD involves mitochondrial dysfunction, oxidative stress, inflammation, and gut dysbiosis.
Purpose of the Study:
- To review the mechanisms of action for photobiomodulation (PBM).
- To explore the potential therapeutic effects of PBM on chronic kidney disease (CKD).
- To assess PBM as a novel treatment for CKD.
Main Methods:
- Literature review of photobiomodulation (PBM) mechanisms.
- Analysis of PBM's effects on CKD-associated pathologies.
- Synthesis of preliminary studies on PBM in kidney disease.
Main Results:
- PBM effectively mitigates mitochondrial dysfunction, oxidative stress, inflammation, and gut microbiota dysbiosis.
- Preliminary evidence suggests PBM benefits in various diseases, including CKD.
- PBM's action mechanisms align with key pathological processes in CKD.
Conclusions:
- Photobiomodulation (PBM) presents a potential non-invasive, non-pharmacological therapeutic strategy for CKD.
- Further research is required to validate PBM's efficacy and safety before widespread clinical recommendation.
- PBM may offer a novel approach to managing chronic kidney disease.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease IV: Nursing Management
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury V: Interprofessional Care

